DCGO.NASDAQDocgo INC

10-Q: DocGo Inc. Reports Q1 2025 Results: Revenue Declines Amid Migrant Services Wind-Down

Sentiment:

Quarterly Report

📋All filings for Docgo INC
🔒Login to Follow

DocGo Inc.'s Q1 2025 revenue decreased by 50% year-over-year due to the wind-down of migrant-related services, resulting in a net loss of $11.1 million.

Worse than expectedThe company's revenue and net income were worse than the same period last year due to the wind-down of migrant-related services.The company's cost of revenues as a percentage of revenue increased, indicating lower profitability.

Summary

  • DocGo Inc. reported a net loss of $11.1 million for the three months ended March 31, 2025, compared to a net income of $10.6 million for the same period in 2024.
  • Total revenues decreased by 50% to $96.0 million, primarily due to the wind-down of migrant-related services within the Mobile Health Services segment.
  • Mobile Health Services revenue decreased by 68.6% to $45.2 million, while Transportation Services revenue increased by 5.4% to $50.8 million.
  • The average trip price for Transportation Services decreased to $378 from $400 in the prior year.
  • Cost of revenues as a percentage of revenues increased to 67.9% from 65.0% in the prior year.
  • Operating expenses decreased by 12.8% to $44.8 million, but increased as a percentage of revenue from 26.8% to 46.7%.
  • The company repurchased 1,953,169 shares of common stock for $5,751,954 during the quarter.
  • The company completed one acquisition for $4.2 million during the quarter.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company is managing costs and has a share repurchase program, the significant revenue decline and net loss raise concerns. The outlook is cautious, with expectations of lower revenue in the coming year.

Positives

  • Transportation Services revenue increased by 5.4%, driven by a 5.9% increase in trip volumes.
  • Operating expenses decreased by 12.8% to $44.8 million.
  • The company is actively managing its share repurchase program.
  • The company is actively managing its cost-containment efforts.

Negatives

  • Total revenues decreased by 50% year-over-year.
  • Net loss of $11.1 million compared to net income of $10.6 million in the same period last year.
  • Mobile Health Services revenue declined significantly due to the wind-down of migrant-related services.
  • Cost of revenues as a percentage of revenues increased to 67.9% from 65.0% in the prior year.
  • The average trip price for Transportation Services decreased to $378 from $400 in the prior year.

Risks

  • The wind-down of migrant-related services has significantly impacted revenue and profitability.
  • Reliance on government contracts subjects the company to audits, investigations, and potential changes in government spending.
  • Economic changes in the markets in which the company operates may impact financial performance.
  • Inflationary pressures may compress gross profit margins.
  • The company is subject to legal proceedings, claims and litigation arising in the ordinary course of business.

Future Outlook

The company expects overall Mobile Health Services revenues to be significantly lower in 2025 than in 2024 due to the wind-down of migrant-related projects. The company anticipates that operating expenses will continue to decline as certain ongoing cost-containment efforts take hold. The company anticipates that its existing balances of cash and cash equivalents, future expected cash flows generated from its operations and amounts available under the Revolving Facility will be sufficient to satisfy operating requirements for at least the next twelve months.

Industry Context

The mobile health services market is dependent on increased patient acceptance of services outside traditional facilities, healthcare coverage, and government funding for underserved populations. The transportation services market is driven by chronic conditions, elective surgeries, and an aging population. The company faces competition in both markets and must adapt to changing economic conditions and regulatory environments.

Comparison to Industry Standards

  • It is difficult to compare DocGo's results directly to industry standards without specific competitor data.
  • However, the decline in revenue due to the wind-down of specific contracts highlights the risk associated with reliance on large, short-term projects, a common challenge in the government contracting space.
  • Companies like American Medical Response (AMR) and Acadian Ambulance Service are major players in the medical transportation industry, but their financial details are not always directly comparable due to differences in business models and reporting structures.
  • The increase in cost of revenues as a percentage of revenue suggests potential inefficiencies or pricing pressures, which would need to be benchmarked against similar companies in the healthcare services sector.
  • The company's focus on technology and dispatch optimization aligns with industry trends towards improving efficiency and patient care coordination, but the effectiveness of these investments needs to be evaluated over time.

Legal Proceedings

  • The company is involved in the Lowe Action, a California labor action alleging various wage and hour claims.
  • The company is involved in the Hall Action, a California labor action alleging various wage and hour claims.
  • The company is involved in a stockholder action, Joe Naclerio, individually and purportedly on behalf of all others similarly situated, filed a putative class action complaint for violation of federal securities laws in the U.S. District Court for the Southern District of New York against the Company
  • The company is involved in a cybersecurity action, Maria Ballesteros, individually and on behalf of others similarly situated, filed a complaint against Ambulnz NY, LLC, a subsidiary of the Company (Ambulnz NY), in the U.S. District Court for the Southern District of New York arising from a data security incident that the Company experienced in April 2024 (the Cybersecurity Action).

Related Party Transactions

  • Ely D. Tendler is compensated for his services to the Company as General Counsel and Secretary through payments to Ely D. Tendler Strategic & Legal Services PLLC (EDTSLS), a law firm owned by Mr. Tendler.
  • PrideStaff provides subcontractor services to the Company. PrideStaff is owned by a former operations manager of the Company and his spouse, and therefore, is a related party.
  • On March 7, 2024, the Company entered into a separation and consulting agreement (the Vashovsky Consulting Agreement) with Stan Vashovsky, who retired as a director and Chair of the Board effective March 31, 2024.
  • On September 26, 2024, the Company entered into a transition consulting agreement (the Katz Consulting Agreement) with Steven Katz, who resigned as a director and independent Chair of the Board of Directors effective October 1, 2024.

Stakeholder Impact

  • Shareholders may be concerned about the decline in revenue and net loss.
  • Employees in the Mobile Health Services segment may be affected by the wind-down of migrant-related services.
  • Customers may experience changes in service availability as the company adjusts its operations.
  • Suppliers may see a decrease in orders as the company manages costs.
  • Creditors should monitor the company's ability to generate cash flow and maintain compliance with debt covenants.

Next Steps

  • The company expects to launch new Mobile Health Services projects in 2025 and to expand existing projects.
  • The company anticipates that operating expenses will continue to decline as certain ongoing cost-containment efforts take hold.
  • The settlement class members will have a period of time to file a claim for the benefits under the settlement before final approval is sought.

Key Dates

DateDescription
June 17, 2015Ambulnz, LLC formed in Delaware.
August 5, 2015Ambulnz Holdings, LLC formed in Delaware.
November 1, 2017Ambulnz converted to a C-corporation and changed its name to Ambulnz, Inc.
January 1, 2019The Company adopted ASC 606, Revenue from Contracts with Customers (ASC 606).
January 1, 2019The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach
November 5, 2021DocGo Inc. consummated the Business Combination with Ambulnz, Inc.
October 26, 2021The Company acquired a 50% interest in RND Health Services Inc. (RND) for $655,876.
November 1, 2022The Company entered into a credit agreement (as amended, the Credit Agreement) with two banks
July 13, 2022Holdings acquired 100% of the outstanding shares of common stock of Exceptional, a provider of medical transportation services, in exchange for $13,708,333
August 9, 2022Holdings acquired 100% of the outstanding shares of common stock of Ryan Brothers, a provider of medical transportation services, in exchange for an aggregate purchase price of $11,422,252
December 9, 2022Holdings, through its indirect wholly owned subsidiary Ambulnz U.K. Ltd. (UK Ltd.), acquired 100% of the outstanding shares of common stock of LMS.
March 30, 2023Paul Lowe v. Rapid Reliable Testing, LLC, et al. was filed in the Los Angeles Superior Court (the Lowe Action).
March 31, 2023Holdings acquired 51% of the outstanding shares of common stock of CRMS, a provider of cardiac implantable electronic device remote monitoring and virtual care management services.
October 11, 2023The Company and Anthony Capone, who resigned as Chief Executive Officer of the Company on September 15, 2023, entered into a separation and transition services agreement (the Transition Agreement).
October 20, 2023The Company obtained an unconditional and irrevocable letter of credit from a financial institution in the amount of $1,080,000.
October 27, 2023Joe Naclerio, individually and purportedly on behalf of all others similarly situated, filed a putative class action complaint for violation of federal securities laws in the U.S. District Court for the Southern District of New York against the Company
January 30, 2024The Board of Directors authorized a share repurchase program to purchase up to $36,000,000 in shares of Common Stock during a six-month period that ended July 30, 2024 (the Prior Repurchase Program).
February 8, 2024The Company drew down an additional $15,000,000 on February 8, 2024 under the Revolving Facility.
February 27, 2024The Company paid the $40,000,000 Revolving Facility balance.
March 4, 2024The Company drew down $15,000,000 and made an additional $15,000,000 draw on March 18, 2024.
March 7, 2024The Company entered into a separation and consulting agreement (the Vashovsky Consulting Agreement) with Stan Vashovsky, who retired as a director and Chair of the Board effective March 31, 2024.
April 2, 2024The Company paid the remaining contingent consideration balance in the amount of $600,029.
May 29, 2024The Company made a portion of the True-up Payment in the amount of $1,000,000.
June 21, 2024The defendants moved to dismiss the amended complaint.
July 1, 2024The Company acquired the remaining noncontrolling interest in its Ambulnz CO, LLC (Ambulnz CO) joint venture from the University of Colorado Health in exchange for $1,848,000 in cash.
July 19, 2024in connection with the CRMS acquisition, the Company issued $1,814,345 in Common Stock, or 578,350 shares, constituting the remainder of the True-up Payment.
August 5, 2024following the expiration of the previously authorized share repurchase program on July 30, 2024, the Board effectively extended the Prior Repurchase Program by authorizing a new share repurchase program (the New Repurchase Program)
August 22, 2024Maria Ballesteros, individually and on behalf of others similarly situated, filed a complaint against Ambulnz NY, LLC, a subsidiary of the Company (Ambulnz NY), in the U.S. District Court for the Southern District of New York arising from a data security incident that the Company experienced in April 2024 (the Cybersecurity Action).
October 25, 2024The Company acquired non-marketable equity securities in Firefly Health, Inc. for $5,000,000.
September 26, 2024The Company entered into a transition consulting agreement (the Katz Consulting Agreement) with Steven Katz, who resigned as a director and independent Chair of the Board of Directors effective October 1, 2024.
December 20, 2024the Board extended the expiration date of the New Repurchase Program from December 31, 2024 to June 30, 2025.
December 20, 2024the Company obtained an irrevocable letter of credit from a financial institution in the amount of $133,303.
February 5, 2025Given the overlapping claims and time periods presented in the California Labor Actions, in an effort to reach a global resolution, these actions were mediated concurrently on February 5, 2025.
February 10, 2025The Company acquired 100% of the outstanding shares of common stock of PTI, a provider of mobile phlebotomy services.
March 21, 2025The plaintiff also filed a motion for preliminary approval of the settlement on March 24, 2025.
March 28, 2025the motion was granted in part and denied in part.
April 25, 2025the remaining defendants answered the complaint.
May 2, 2025the court entered an order granting preliminary approval of the parties settlement agreement, directing notice to the settlement class and scheduling a final fairness hearing for August 22, 2025.
August 22, 2025The settlement class members will have a period of time to file a claim for the benefits under the settlement before final approval is sought.

Keywords

DocGo, financial results, Q1 2025, revenue, mobile health services, transportation services, migrant services, net loss, share repurchase, acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.